{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:04:25Z","timestamp":1777982665873,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s11102-026-01641-5","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T18:51:57Z","timestamp":1770663117000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Subsequent primary malignancies in patients with initial diagnosis of pituitary adenoma: a surveillance, epidemiology, and end results (SEER) data analysis"],"prefix":"10.1007","volume":"29","author":[{"given":"Maxwell W.","family":"Pickles","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas Z.","family":"Rohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sydney M.","family":"Macon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preston","family":"Carey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Murayi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David P.","family":"Bray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James J.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"issue":"1","key":"1641_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1055\/a-1029-2878","volume":"52","author":"ML Gheorghiu","year":"2020","unstructured":"Gheorghiu ML, Negreanu F, Fleseriu M (2020) Updates in the medical treatment of pituitary adenomas. Horm Metab Res 52(1):8\u201324. https:\/\/doi.org\/10.1055\/a-1029-2878","journal-title":"Horm Metab Res"},{"issue":"3","key":"1641_CR2","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ecl.2020.05.001","volume":"49","author":"AF Daly","year":"2020","unstructured":"Daly AF, Beckers A (2020) The epidemiology of pituitary adenomas. Endocrinol Metab Clin North Am 49(3):347\u2013355. https:\/\/doi.org\/10.1016\/j.ecl.2020.05.001","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"Suppl 5","key":"1641_CR3","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/noz150","volume":"21","author":"QT Ostrom","year":"2019","unstructured":"Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C et al (2019) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012\u20132016. Neuro Oncol 21(Suppl 5):v1\u2013v100. https:\/\/doi.org\/10.1093\/neuonc\/noz150","journal-title":"Neuro Oncol"},{"issue":"2","key":"1641_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.17712\/nsj.2017.2.20160641","volume":"22","author":"HM Al-Dorzi","year":"2017","unstructured":"Al-Dorzi HM, Alruwaita AA, Marae BO, Alraddadi BS, Tamim HM, Ferayan A et al (2017) Incidence, risk factors and outcomes of seizures occurring after craniotomy for primary brain tumor resection. Neurosciences (Riyadh) 22(2):107\u2013113. https:\/\/doi.org\/10.17712\/nsj.2017.2.20160641","journal-title":"Neurosciences (Riyadh)"},{"issue":"16","key":"1641_CR5","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1001\/jama.2023.2407","volume":"329","author":"NA Tritos","year":"2023","unstructured":"Tritos NA, Miller KK (2023) Diagnosis and management of pituitary adenomas: a review. JAMA 329(16):1386\u20131398. https:\/\/doi.org\/10.1001\/jama.2023.2407","journal-title":"JAMA"},{"issue":"1","key":"1641_CR6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.17925\/EE.2019.15.1.30","volume":"15","author":"EV Varlamov","year":"2019","unstructured":"Varlamov EV, McCartney S, Fleseriu M (2019) Functioning pituitary adenomas \u2013 current treatment options and emerging medical therapies. Eur Endocrinol 15(1):30\u201340. https:\/\/doi.org\/10.17925\/EE.2019.15.1.30","journal-title":"Eur Endocrinol"},{"issue":"8","key":"1641_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers9080103","volume":"9","author":"R Yamanaka","year":"2017","unstructured":"Yamanaka R, Abe E, Sato T, Hayano A, Takashima Y (2017) Secondary intracranial tumors following radiotherapy for pituitary adenomas: a systematic review. Cancers (Basel) 9(8):103. https:\/\/doi.org\/10.3390\/cancers9080103","journal-title":"Cancers (Basel)"},{"issue":"2","key":"1641_CR8","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1210\/jc.2004-1164","volume":"90","author":"G Minniti","year":"2005","unstructured":"Minniti G, Traish D, Ashley S, Gonsalves A, Brada M (2005) Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years. J Clin Endocrinol Metab 90(2):800\u2013804. https:\/\/doi.org\/10.1210\/jc.2004-1164","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1641_CR9","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1007\/s10552-022-01609-3","volume":"33","author":"M Ben Lassan","year":"2022","unstructured":"Ben Lassan M, Laitman Y, Keinan-Boker L, Silverman B, Friedman E (2022) Secondary cancer after meningioma diagnosis: an Israeli national study. Cancer Causes Control 33(10):1277\u20131284. https:\/\/doi.org\/10.1007\/s10552-022-01609-3","journal-title":"Cancer Causes Control"},{"issue":"8","key":"1641_CR10","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S2213-8587(22)00157-2","volume":"10","author":"R Hamblin","year":"2022","unstructured":"Hamblin R, Vardon A, Akpalu J, Tampourlou M, Spiliotis I, Sbardella E et al (2022) Risk of second brain tumour after radiotherapy for pituitary adenomaor craniopharyngioma: a retrospective, multicentre, cohort study of 3679 patients with long-term imaging surveillance. Lancet Diabetes Endocrinol 10(8):581\u2013588. https:\/\/doi.org\/10.1016\/S2213-8587(22)00157-2","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"1641_CR11","doi-asserted-by":"publisher","first-page":"T273","DOI":"10.1530\/ERC-14-0053","volume":"21","author":"ML Gheorghiu","year":"2014","unstructured":"Gheorghiu ML, Negreanu F, Fleseriu M (2014) Estrogen and its role in the pathogenesis of pituitary tumors. Endocr Relat Cancer 21(5):T273\u2013T283. https:\/\/doi.org\/10.1530\/ERC-14-0053","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"1641_CR12","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/EO-21-0033","volume":"2","author":"S Pekic","year":"2022","unstructured":"Pekic S, Stojanovic M, Popovic V (2022) Pituitary tumors and the risk of other malignancies: is the relationship coincidental or causal? Endocr Oncol 2(1):R1\u2013R13. https:\/\/doi.org\/10.1530\/EO-21-0033","journal-title":"Endocr Oncol"},{"issue":"2","key":"1641_CR13","first-page":"147","volume":"49","author":"KD Bertakis","year":"2000","unstructured":"Bertakis KD, Azari R (2000) Gender differences in the utilization of health care services. J Fam Pract 49(2):147\u2013152 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/10718692\/","journal-title":"J Fam Pract"},{"issue":"1","key":"1641_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/biomedicines12010023","volume":"12","author":"C Toader","year":"2024","unstructured":"Toader C, Dobrin N, Tataru C-I et al (2024) From genes to therapy: pituitary adenomas in the era of precision medicine. Biomedicines. 12(1):23. https:\/\/doi.org\/10.3390\/biomedicines12010023","journal-title":"Biomedicines."},{"issue":"11","key":"1641_CR15","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1002\/cam4.871","volume":"5","author":"T Shanmugalingam","year":"2016","unstructured":"Shanmugalingam T, Bosco C, Ridley AJ, Van Hemelrijck M (2016) Is there a role for IGF-1 in the development of second primary cancers? Cancer Med 5(11):3353\u20133367. https:\/\/doi.org\/10.1002\/cam4.871","journal-title":"Cancer Med"},{"key":"1641_CR16","doi-asserted-by":"publisher","unstructured":"Brada M, Ford D, Ashley S et al (1993) Risk of second brain tumor after radiotherapy for pituitary adenoma. J Clin Endocrinol Metab 77(5):1283\u20131286. https:\/\/doi.org\/10.1210\/jcem.77.5.8077333 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/8334743\/","DOI":"10.1210\/jcem.77.5.8077333"},{"issue":"12","key":"1641_CR17","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1093\/neuonc\/noae133","volume":"26","author":"C Dumot","year":"2024","unstructured":"Dumot C, Mantziaris G, Dayawansa S et al (2024) Risk of new tumor, carotid stenosis, and stroke after stereotactic radiosurgery for pituitary tumor: a multicenter study of 2254 patients with imaging follow-up. Neuro-Oncology 26(12):2328\u20132338. https:\/\/doi.org\/10.1093\/neuonc\/noae133","journal-title":"Neuro-Oncology"},{"issue":"5","key":"1641_CR18","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.ijrobp.2016.12.021","volume":"97","author":"BE Pollock","year":"2017","unstructured":"Pollock BE, Link MJ, Stafford SL, Garces YI, Foote RL (2017) The risk of radiation-induced tumors or malignant transformation after single-fraction intracranial radiosurgery. Int J Radiat Oncol Biol Phys 97(5):919\u2013923. https:\/\/doi.org\/10.1016\/j.ijrobp.2016.12.021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1641_CR19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1182\/asheducation-2016.1.293","volume":"2016","author":"RB McGee","year":"2016","unstructured":"McGee RB, Nichols KE (2016) Introduction to cancer genetic susceptibility syndromes. Hematol Am Soc Hematol Educ Program 2016(1):293\u2013301. https:\/\/doi.org\/10.1182\/asheducation-2016.1.293","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"1641_CR20","unstructured":"Singh G, Mulji NJ, Jialal I. Multiple endocrine neoplasia type 1. In: StatPearls [internet]. Treasure Island (FL): StatPearls Publishing; 2024. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK536980\/"},{"issue":"2","key":"1641_CR21","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1210\/jcem.87.2.8180","volume":"87","author":"B Verg\u00e8s","year":"2002","unstructured":"Verg\u00e8s B, Boureille F, Goudet P et al (2002) Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study. J Clin Endocrinol Metab 87(2):457\u2013465. https:\/\/doi.org\/10.1210\/jcem.87.2.8180","journal-title":"J Clin Endocrinol Metab"},{"key":"1641_CR22","unstructured":"Russ S, Anastasopoulou C, Shafiq I. Pituitary adenoma. In: StatPearls [internet] (FL): StatPearls Publishing; 2024. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK554451\/"},{"key":"1641_CR23","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s11102-016-0744-z","volume":"20","author":"A Tirosh","year":"2017","unstructured":"Tirosh A, Shimon I (2017) Complications of acromegaly: thyroid and colon. Pituitary 20:70\u201375. https:\/\/doi.org\/10.1007\/s11102-016-0744-z","journal-title":"Pituitary"},{"issue":"22","key":"1641_CR24","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2024.39.e185","volume":"39","author":"S Jun","year":"2024","unstructured":"Jun S, Park H, Kim UJ et al (2024) The combined effects of alcohol consumption and smoking on cancer risk by exposure level: a systematic review and meta-analysis. J Korean Med Sci 39(22):e185. https:\/\/doi.org\/10.3346\/jkms.2024.39.e185","journal-title":"J Korean Med Sci"},{"issue":"2","key":"1641_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/dom.12124","volume":"16","author":"SK Garg","year":"2014","unstructured":"Garg SK, Maurer H, Reed K, Selagamsetty R (2014) Diabetes and cancer: two diseases with obesity as a common risk factor. Diabetes Obes Metab 16(2):97\u2013110. https:\/\/doi.org\/10.1111\/dom.12124","journal-title":"Diabetes Obes Metab"},{"key":"1641_CR26","unstructured":"Beck-Peccoz P, Persani L, Lania A. Thyrotropin-Secreting Pituitary adenomas. In: Endotext [Internet]. MDText.com, Inc.; 2022. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK278978\/"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01641-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-026-01641-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01641-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T17:38:34Z","timestamp":1773682714000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-026-01641-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1641"],"URL":"https:\/\/doi.org\/10.1007\/s11102-026-01641-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7810484\/v1","asserted-by":"object"}]},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"8 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted using de-identified, publicly available data from the Surveillance, Epidemiology, and End Results (SEER) database. Therefore, ethical approval and informed consent were not required in accordance with institutional and national research committee standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}